U.S. Sarcopenia Treatment Market to 2032
Overview
The U.S. Sarcopenia Treatment Market is expected to reach a 1.60 USD Billion by 2032 and is projected to grow at a CAGR of 7.30% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.07
Forecast, 2032 (USD Billion)
1.60
CAGR, 2024 - 2032
7.30%
Report Coverage
U.S.
U.S. Sarcopenia Treatment Market 2018-2032 USD Billion
U.S. Sarcopenia Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.07 USD Billion
- Projected Market Size (2032): 1.60 USD Billion
- CAGR (2025-2032): 7.30%
Key Findings of U.S. Sarcopenia Treatment Market
- The U.S. Sarcopenia Treatment Market was valued at 1.07 USD Billion in 2024.
- The U.S. Sarcopenia Treatment Market is likely to grow at a CAGR of 7.30% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Male in Gender Segment accounted for the largest share of the market with a revenue of 0.66 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 8.81% during the forecast period from 2024 to 2032.
U.S. Sarcopenia Treatment Market Scope
U.S. Sarcopenia Treatment Market Segmentation & Scope
Type
- Secondary Sarcopenia
- Primary Sarcopenia
Stages
- Severe Sarcopenia
- Sarcopenia
- Pre-Sarcopenia
Route of Administration
- Others
- Injectables
- Oral
Gender
- Female
- Male
End User
- Others
- Home Healthcare
- Speciality Clinics
- Hospitals
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Treatment Type
- Others
- Medications1
- Vitamin/Dietary Supplements1
U.S. Sarcopenia Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.07 USD Billion |
| Market Value in 2032 | 1.60 USD Billion |
| CAGR (2025-2032) | 7.30% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Stages,Route of Administration,Gender,End User,Distribution Channel,Treatment Type |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 1.07 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,065.12 USD Million in 2024.
Segments and Scope
-
U.S. Sarcopenia Treatment Market to 2032, By Type
- Primary Sarcopenia is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 632.15 USD Billion in the year 2024.
- Primary Sarcopenia is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 7.99 % in forecast period 2025-2032.
-
U.S. Sarcopenia Treatment Market to 2032, By Stages
- Pre-Sarcopenia is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 519.30 USD Billion in the year 2024.
- Pre-Sarcopenia is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 8.42 % in forecast period 2025-2032.
-
U.S. Sarcopenia Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 509.68 USD Billion in the year 2024.
- Oral is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 8.46 % in forecast period 2025-2032.
-
U.S. Sarcopenia Treatment Market to 2032, By Gender
- Male is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 661.48 USD Billion in the year 2024.
- Male is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 7.83 % in forecast period 2025-2032.
-
U.S. Sarcopenia Treatment Market to 2032, By End User
- Hospitals is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 516.29 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 8.81 % in forecast period 2025-2032.
-
U.S. Sarcopenia Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 588.99 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 7.84 % in forecast period 2025-2032.
-
U.S. Sarcopenia Treatment Market to 2032, By Treatment Type
- Vitamin/Dietary Supplements1 is the largest segment in U.S. Sarcopenia Treatment Market to 2032 with a revenue of 506.07 USD Billion in the year 2024.
- Vitamin/Dietary Supplements1 is the Fastest growing segment in U.S. Sarcopenia Treatment Market to 2032 with a Growth rate of 8.12 % in forecast period 2025-2032.
U.S. Sarcopenia Treatment Market Company Share Analysis
| Company Name |
|
||
| Nestlé | |||
| Novartis AG | |||
| Sanofi | |||
| BASF SE | |||
| Abbott | |||
U.S. Sarcopenia Treatment Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Sarcopenia Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Sarcopenia Treatment Market is segmented based on Segmentation Type,Stages,Route of Administration,Gender,End User,Distribution Channel,Treatment Type.
U.S. Sarcopenia Treatment Market was valued at USD 1.07(Revenue in USD Billion) in 2021.
U.S. Sarcopenia Treatment Market is projected to grow at a CAGR of 7.30% during the forecast period of 2024 to 2032.
The Male segment is expected to dominate the U.S. Sarcopenia Treatment Market, holding a largest market share of 0.66 USD Billion in 2024
U.S. Sarcopenia Treatment Market Scope
U.S. Sarcopenia Treatment Market Segmentation & Scope
Type
- Secondary Sarcopenia
- Primary Sarcopenia
Stages
- Severe Sarcopenia
- Sarcopenia
- Pre-Sarcopenia
Route of Administration
- Others
- Injectables
- Oral
Gender
- Female
- Male
End User
- Others
- Home Healthcare
- Speciality Clinics
- Hospitals
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Treatment Type
- Others
- Medications1
- Vitamin/Dietary Supplements1
Frequently Asked Questions
The U.S. Sarcopenia Treatment Market is segmented based on Segmentation Type,Stages,Route of Administration,Gender,End User,Distribution Channel,Treatment Type.
U.S. Sarcopenia Treatment Market was valued at USD 1.07(Revenue in USD Billion) in 2021.
U.S. Sarcopenia Treatment Market is projected to grow at a CAGR of 7.30% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Sarcopenia Treatment Market for final year is USD 1.60 (USD Billion).
U.S. Sarcopenia Treatment Market Company Profiling
Frequently Asked Questions
The U.S. Sarcopenia Treatment Market is segmented based on Segmentation Type,Stages,Route of Administration,Gender,End User,Distribution Channel,Treatment Type.
U.S. Sarcopenia Treatment Market was valued at USD 1.07(Revenue in USD Billion) in 2021.
U.S. Sarcopenia Treatment Market is projected to grow at a CAGR of 7.30% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Sarcopenia Treatment Market for final year is USD 1.60 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.